Your browser doesn't support javascript.
loading
Mutation of cysteine residues alters the heme-binding pocket of indoleamine 2,3-dioxygenase-1.
Austin, Christopher J D; Kosim-Satyaputra, Priambudi; Smith, Jason R; Willows, Robert D; Jamie, Joanne F.
  • Austin CJ; Department of Chemistry and Biomolecular Sciences, Macquarie University, Sydney, Australia.
Biochem Biophys Res Commun ; 436(4): 595-600, 2013 Jul 12.
Article en En | MEDLINE | ID: mdl-23751345
ABSTRACT
The hemoprotein indoleamine 2,3-dioxygenase-1 (IDO1) is the first and rate-limiting enzyme in mammalian tryptophan metabolism. Interest in IDO1 continues to grow, due to the ever expanding influence IDO1 plays in the immune response. This study examined the contribution of all individual cysteine residues towards the overall catalytic properties and stability of recombinant human IDO1 via mutagenesis studies using a range of biochemical and spectroscopic techniques, including in vitro kinetic assessment, secondary structure identification via circular dichroism spectroscopy and thermal stability assessment. Upon mutation of cysteine residues we observed changes in secondary structure (principally, shifting from α-helix/ß-sheet features to random coil structures) that produced out of plane heme torsion and puckering, changes to thermal stability (including gains in stability for one mutant protein) and differences in enzymatic activity (such as, increased ability to convert non-natural substrates, e.g.d-tryptophan) from wild type IDO1 enzyme.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cisteína / Indolamina-Pirrol 2,3,-Dioxigenasa / Hemo Límite: Humans Idioma: En Año: 2013 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cisteína / Indolamina-Pirrol 2,3,-Dioxigenasa / Hemo Límite: Humans Idioma: En Año: 2013 Tipo del documento: Article